G8 Countries Non-Life Insurance Market Summary, Competitive Analysis and Forecast, 2018-2027
Summary
The G8 Non-Life Insurance industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
The G8 countries contributed $2,861.9 billion in 2022 to the global non-life insurance industry, with a compound annual growth rate (CAGR) of 5.1% between 2018 and 2022. The G8 countries are expected to reach a value of $3,550.4 billion in 2027, with a CAGR of 4.4% over the 2022-27 period.
Among the G8 nations, the US is the leading country in the non-life insurance industry, with market revenues of $2,170.3 billion in 2022. This was followed by Germany and the UK, with a value of $174.6 and $122.7 billion, respectively.
The US is expected to lead the non-life insurance industry in the G8 nations with a value of $2,642.0 billion in 2016, followed by Germany and Japan with expected values of $248.9 and $154.5 billion, respectively.
Scope
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the G8 non-life insurance market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 non-life insurance market
Leading company profiles reveal details of key non-life insurance market players’ G8 operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the G8 non-life insurance market with five year forecasts
Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country
Reasons to Buy
What was the size of the G8 non-life insurance market by value in 2022?
What will be the size of the G8 non-life insurance market in 2027?
What factors are affecting the strength of competition in the G8 non-life insurance market?
How has the market performed over the last five years?
Who are the top competitors in the G8 non-life insurance market?